Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Effects of caffeine supplementation on lipid profile and handgrip strength in cirrhotic patients: a randomized, placebo- controlled, clinical trial
- Abbas-Hashemi S.A. , et al.
2. Association between metabolic signatures of predicted VAT mass and risk of MASLD and other chronic liver diseases
- Wang S.A. , et al.
3. Evaluation of hepatoprotective activity of Murvadi Agada-A polyherbal formulation in Methotrexate induced hepatotoxicity in Wistar albino rats.
- Mangattu S. , et al.
4. Employing low-density lipoprotein-based delivery systems for the treatment of hepatocellular carcinoma
- Kolli M. , et al.
5. Non-invasive prediction of significant hepatic fibrosis in individuals with chronic hepatitis C infection using fibrosis risk score and machine learning models
- Bashir A. , et al.
6. Hepatoprotective potential of Urochloa distachya (L.) ethanol extract against paracetamol and CCl4-induced liver injury in rats
- Dash S. , et al.
7. Dyslipidemia in liver cirrhosis: Pathophysiology and emerging therapeutic approaches
- Fuentes-Mendoza J.M. , et al.
8. Stage-dependent gut microbiome and functional signatures across the liver disease spectrum: an integrative multicohort study
- Vázquez-Castellanos J.F. , et al.
9. Lipid metabolism disturbance and immune dysfunction in HBV-related acute-on-chronic liver failure: a retrospective cohort study
- Wang N. , et al.
10. Hepatoprotective potential of M3F, a benzimidazole pyrazole derivative, against paracetamol induced hepatotoxicity
- Ilyas Z. , et al.
11. The prognostic impact of statin exposure in metabolic dysfunction-associated steatotic liver disease: a cohort study
- Yang K. , et al.
12. Clinical characteristics of dyslipidemia in patients with primary biliary cholangitis: a single-center experience in China
- Wang X. , et al.
13. Hepatoprotective effects of a Cassia fistula fruit extract and molecular insights into its phytoconstituents’ interactions with Keap1
- Ahmed B.M.F. , et al.
14. Colemanite and biological disruptions: Behavioral, neurological, and physiological findings
- Türkez H. , et al.
15. Exploring the Hepatoprotective Effects of Naringin: A Systematic Review and Meta-Analysis of Preclinical Evidence
- Fayaz M. , et al.
16. The Impact of Non-Invasive Scores and Hemogram-Derived Ratios in Differentiating Chronic Liver Disease from Cirrhosis
- Ismaiel A. , et al.
17. Transdermal Semaglutide Administration in Mice: Reduces Body Weight by Suppressing Appetite and Enhancing Metabolic Rate
- Li W. , et al.
18. Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C
- Ryu T. , et al.
19. Hepatoprotective efficacy of Argemone mexicana L. root in paracetamol-induced hepatotoxicity in a rat model
- Bagchi A. , et al.
20. Hepatoprotective and PXR-modulating effects of Erodium guttatum extract in propiconazole-induced toxicity
- Ounissi I. , et al.
21. Low-density lipoprotein cholesterol and clinical outcomes in patients with liver cirrhosis: a nationwide cohort study
- Kim B.S. , et al.
22. Ononin promotes survival rate in cecal ligation puncture-induced sepsis rat model by regulating inflammatory pathway
- Liu B. , et al.
23. Intermittent fasting alleviates high-fat-diet-induced fatty liver disease via TGF-β1 and MMP-9 regulation in albino rats
- A. Alqahtani H. , et al.